The present invention pertains to a novel lappaconitine derivative, a method for producing same, and a pharmaceutical use thereof using osteogenesis-promoting activity. The lappaconitine derivative induces the differentiation of stem cells into osteoblasts, increases bone mineral density when administered to animal models of osteoporosis, and induces bone formation in animal models of bone fracture, and thus can be advantageously used for preventing, ameliorating, or treating bone-related diseases such as osteoporosis, as well as treating non-disease fractures caused by physical trauma.
C07D 223/32 - Composés hétérocycliques contenant des cycles à sept chaînons ne comportant qu'un atome d'azote comme unique hétéro-atome du cycle condensés avec des carbocycles ou avec des systèmes carbocycliques contenant des carbocycles autres que des cycles à six chaînons
A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
2.
NOVEL OXIDIZED LAPPACONITINE DERIVATIVE AND USE THEREOF
The present invention relates to a novel lappaconitine derivative and a pharmaceutically acceptable salt thereof, a preparation method therefor, and a medical use thereof using osteogenesis-promoting activity. The lappaconitine derivative induces the differentiation of stem cells into preosteoblasts, and increases bone density when administered to an osteoporosis animal model, and induces osteogenesis, and thus can be effectively used for preventing, alleviating, or treating bone-related diseases such as osteoporosis.
C07D 223/32 - Composés hétérocycliques contenant des cycles à sept chaînons ne comportant qu'un atome d'azote comme unique hétéro-atome du cycle condensés avec des carbocycles ou avec des systèmes carbocycliques contenant des carbocycles autres que des cycles à six chaînons
A61K 31/55 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole
A61P 19/10 - Médicaments pour le traitement des troubles du squelette des maladies osseuses, p. ex. rachitisme, maladie de Paget de l'ostéoporose
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
3-in-1 hair shampoos; make-up; cosmetic preparations for the hair and scalp; hair care preparations; cosmetic preparations for baths; beauty soap; shampoos; hand cleansers; whitening essences for skincare; cosmetic preparations for skin care; essential oils; tooth cleaning gels; toothpaste; foam cleansers for the skin; hair rinses; hair essences; toilet water; beauty masks; non-medicated hair treatment preparations for cosmetic purposes; cosmetics. nutraceuticals based on eggs; protein dietary supplements; hair growth stimulants; vitamins and mineral dietary supplements; pharmaceutical preparations for skin care; nutraceuticals for use as a dietary supplement; dietary supplements consisting of amino acids, minerals, and micronutrients; acne treatment preparations; medicated scalp treatment cream; medicated hair care preparations; medicated shampoos; medicated dietary supplements; medicated hair growth preparations; medicated toothpaste; medicated skin care preparations; pharmaceutical compounds; medicinal creams; pharmaceutical preparations; nutraceuticals for treatment and medical purposes; mixed vitamin preparations.
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
3-in-1 hair shampoos; make-up; cosmetic preparations for the hair and scalp; hair care preparations; cosmetic preparations for baths; beauty soap; shampoos; hand cleansers; skin whitening preparations, namely, skin essences; cosmetic preparations for skin care; essential oils; tooth cleaning gels; toothpaste; skin cleansers in the nature of foam cleansers for the skin; hair rinses; hair essences in the nature of hair care creams; toilet water; beauty masks; non-medicated hair treatment preparations for cosmetic purposes; cosmetics Nutraceuticals for use as a dietary supplement in the nature of nutraceuticals based mainly on eggs; protein dietary supplements; hair growth stimulants; vitamins and mineral dietary supplements; pharmaceutical preparations for skin care; nutraceuticals for use as a dietary supplement; dietary supplements consisting of amino acids, minerals, and micronutrients; acne treatment preparations; medicated scalp treatment cream; medicated hair care preparations; medicated shampoos; medicated dietary supplements for foodstuff for humans; medicated hair growth preparations; medicated toothpaste; medicated skin care preparations; biometallic compounds being a component in pharmaceutical preparations for bone fractures; medicinal creams for skin care; nutraceuticals for treatment and medical purposes, namely, for the treatment of constipation and osteoporosis; mixed vitamin preparations
5.
SANGUISORBA OFFICINALIS LINNE EXTRACT COMPOSITION INHIBITING 3CL PROTEASE AND RDRP ACTIVITY OF SARS-COV-2
The present invention relates to a novel use of a Sanguisorba officinalis Linne extract in inhibiting the 3CL protease and RdRp activity of SARS-CoV-2 virus, and a composition of the present invention comprising the Sanguisorba officinalis Linne extract as an active ingredient has the effect of preventing or treating infection with SARS-CoV-2 virus or variants thereof by inhibiting the 3CL protease and RdRp activity.
The present invention relates to a novel oxidized lappaconitine derivative and a pharmaceutically acceptable salt thereof, a preparation method therefor, and a medical use thereof using osteogenesis-promoting activity. The lappaconitine derivative induces the differentiation of stem cells into preosteoblasts, and increases bone density when administered to an osteoporosis animal model, and induces osteogenesis, and thus can effectively used for preventing, alleviating, or treating bone-related diseases such as osteoporosis.
C07D 223/32 - Composés hétérocycliques contenant des cycles à sept chaînons ne comportant qu'un atome d'azote comme unique hétéro-atome du cycle condensés avec des carbocycles ou avec des systèmes carbocycliques contenant des carbocycles autres que des cycles à six chaînons
A61K 31/55 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole
A61P 19/00 - Médicaments pour le traitement des troubles du squelette
A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
The present invention pertains to a novel lappaconitine derivative, a method for producing same, and a pharmaceutical use thereof using osteogenesis-promoting activity. The lappaconitine derivative induces the differentiation of stem cells into osteoblasts, increases bone density when administered to animal models of osteoporosis, and induces bone formation in animal models of bone fracture, and thus can be advantageously used for preventing, ameliorating, or treating bone-related diseases such as osteoporosis, as well as for treating non-disease fractures caused by physical trauma.
C07D 223/32 - Composés hétérocycliques contenant des cycles à sept chaînons ne comportant qu'un atome d'azote comme unique hétéro-atome du cycle condensés avec des carbocycles ou avec des systèmes carbocycliques contenant des carbocycles autres que des cycles à six chaînons
A61K 31/55 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole
A61P 19/00 - Médicaments pour le traitement des troubles du squelette
A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
Produits et services
Solid-type makeup soap being beauty soap; cosmetic preparations for skin care; shampoo; non-medicated scalp protection and treatment cream; make-up; hair essence being hair styling preparations; cosmetic preparations for bath and shower; non-medicated skin care lotion; essential oils; tooth whitening and cleansing gel; toothpaste; face and body care cosmetics; skin cleansing foam being foam cleansers for personal use; perfume; hair conditioner; non-medicated skin toner; cosmetic mask; flower essences for cosmetic purposes
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
Produits et services
Solid-type makeup soap being beauty soap; cosmetic preparations for skin care; shampoo; non-medicated scalp protection and treatment cream; make-up; hair essence being hair styling preparations; cosmetic preparations for bath and shower; non-medicated skin care lotion; essential oils; tooth whitening and cleansing gel; toothpaste; face and body care cosmetics; skin cleansing foam being foam cleansers for personal use; perfume; hair conditioner; non-medicated skin toner; cosmetic mask; flower essences for cosmetic purposes
